Amundi Asset Management US’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-30,500
Closed -$117K 1606
2018
Q3
$117K Buy
30,500
+13,500
+79% +$47.2K ﹤0.01% 1510
2018
Q2
$56K Hold
17,000
﹤0.01% 1511
2018
Q1
$76K Buy
17,000
+1,800
+12% +$6.06K ﹤0.01% 1445
2017
Q4
$38K Buy
+15,200
New +$45.2K ﹤0.01% 1528

Other funds holding CGEN

Amundi Asset Management US's CGEN Position: Q4 2018 in Review

Amundi Asset Management US sold out of Compugen (CGEN) in Q4 2018, closing a stake of 30,500 shares — an estimated $117K sold.

Amundi Asset Management US first reported a position in CGEN in Q4 2017 and held it in 4 quarters. The position peaked at $117K in Q3 2018. 39 funds tracked by Wall St. Rank hold CGEN as of Q4 2018.

  • Amundi Asset Management US reported no remaining Compugen position as of Q4 2018 after selling out during the quarter.
  • Amundi Asset Management US sold 30,500 Compugen shares in Q4 2018, an estimated $117K.
  • Amundi Asset Management US first reported a position in Compugen in Q4 2017 and held it in 4 quarters.
  • Amundi Asset Management US's Compugen position peaked at $117K in Q3 2018.
  • 39 funds tracked by Wall St. Rank held Compugen as of Q4 2018.

Based on Amundi Asset Management US's 13F filing for Q4 2018, filed 14 Feb 2019.